This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Sep;9(5):339-40.

doi: 10.1097/00054725-200309000-00011.

Making a good thing last: the effect of intravenous hydrocortisone premedication on the immunogenicity of infliximab

Sarathchandra I Reddy¹

Affiliations

PMID: 14570010
DOI: 10.1097/00054725-200309000-00011

Comment

Making a good thing last: the effect of intravenous hydrocortisone premedication on the immunogenicity of infliximab

Sarathchandra I Reddy. Inflamm Bowel Dis. 2003 Sep.

. 2003 Sep;9(5):339-40.

doi: 10.1097/00054725-200309000-00011.

Author

Sarathchandra I Reddy¹

Affiliation

¹ Harvard Medical School, Division of Gastroenterology, Brigham and Women's Hospital Boston, Massachusetts, USA.

PMID: 14570010
DOI: 10.1097/00054725-200309000-00011

No abstract available

PubMed Disclaimer

Comment on

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial.
Farrell RJ, Alsahli M, Jeen YT, Falchuk KR, Peppercorn MA, Michetti P. Farrell RJ, et al. Gastroenterology. 2003 Apr;124(4):917-24. doi: 10.1053/gast.2003.50145. Gastroenterology. 2003. PMID: 12671888 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.